Assisted Reproductive Technology Market Size, Share & Trends Report

Assisted Reproductive Technology Market Size, Share & Trends Analysis Report By Type (IVF, Artificial Insemination), By End-use (Fertility Clinics & Other Facilities, Hospitals & Other Settings), By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: 978-1-68038-494-9
  • Number of Report Pages: 100
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2021
  • Forecast Period: 2023 - 2030 
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the assisted reproductive technology market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for assisted reproductive technology market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of assisted reproductive technology market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Assisted Reproductive Technology Market Categorization:

The assisted reproductive technology market was categorized into three segments, namely type (In-Vitro Fertilization, Artificial Insemination), end-use (Fertility clinics & other facilities, Hospitals & Others), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The assisted reproductive technology market was segmented into type, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The assisted reproductive technology market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into eighteen countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Japan; China; India; Australia, South Korea, Mexico; Brazil; Argentina, South Africa, Saudi Arabia, UAE.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Assisted reproductive technology market companies & financials:

The assisted reproductive technology market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • MICROM UK LTD. - Microm UK Ltd. is a leading provider of assisted reproduction, embryology, and sperm analysis products. In 1994, Microm UK Ltd. became the sole supplier of FertiPro N.V., a leading producer of a vast array of products for sperm analysis and assisted reproduction techniques in the UK and Ireland. Microm UK Ltd. is the exclusive distributor for Leja Products B.V., FertiPro N.V., and MICROPTIC S.L. in the two countries. The company also distributes products from Microptic, HalotecDNA, Linkam Scientific, and Apex Medical Technologies, Inc. among others.

  • VITROLIFE AB (PUBL) - olife was one of the first companies that offered ready-to-use culture media for IVF laboratories. It has a vast range of IVF products and a global presence with more than 10 offices & 80 distributors and worldwide production. Vitrolife maintains a high-quality distribution channel that includes product retrieval and transfer. Its product range includes nutrient solutions for handling and culturing sperm, eggs, and embryos, needles for oocyte retrieval, micromanipulation pipettes, and disposable plastic products. It also offers products for cryopreservation of eggs, sperm, and embryos.

  • THE COOPER COMPANIES, INC. - The Cooper Companies, Inc. is a global medical devices company with a presence in more than 100 countries. It provides medical devices and procedure solutions. The company also develops, manufactures, and markets diagnostic systems, medical devices, and surgical instruments for gynecologists and other women’s healthcare providers. It operates through two business units: CooperSurgical and CooperVision. The product portfolio of CooperSurgical includes cervical cancer screening systems, bone density scanners, examination instruments, insemination tools, fetal monitors, and surgical sterilization devices. The company markets its products to hospitals, doctors' offices, and healthcare clinics.

  • FUJIFILM IRVINE SCIENTIFIC - FUJIFILM Irvine Scientific is a member of Fujifilm Holdings Corporation. The company manufactures cell media cultures and reagents & for medical devices for researchers and clinicians. It specializes in areas including Assisted Reproductive Technology (ART), cytogenetics, biologics and biosimilar, specialty media products, cell culture media, and cell therapy. It complies with ISO, FDA, and cGMP guidelines and has manufacturing facilities in the U.S. and Tokyo.

  • GENEA BIOMEDX - Genea Biomedx, a fertility and IVF clinic, is a part of the Genea family. It designs and manufactures IVF devices to standardize and automate fertility treatments. Genea is Australia's third-largest reproductive services player. It is majorly involved in the research of innovative IVF technologies. The company, formerly known as Sydney IVF, commercializes IVF products, medical devices, fertility devices, Geri, Gavi, and Gems.

  • FERRING PHARMACEUTICAL B.V. - Ferring Pharmaceuticals B.V. is a biopharmaceutical company focusing on research of innovative and personalized healthcare solutions. The company is developing and marketing pharmaceutical products in line with the treatment of life-threatening conditions. The company offers products for reproductive medicine and maternal health, gastroenterology, urology and uro-oncology, endocrinology, and orthopedics. Ferring is a leading provider of assisted reproductive technology for fertility treatment and offers peptide-based medicines to prevent preterm labor. The company’s key therapeutic areas include reproductive health, urology, gastroenterology, and endocrinology.

  • MERCK KGAA - Merck KGaA is a scientific and technology firm that produces pharmaceutical and chemical products. It deals with healthcare, life sciences, and electronic industry. The healthcare segment manufactures and develops prescription medicines for multiple sclerosis, cancer, and infertility treatments. The life sciences segment provides laboratory tools, materials, and services to researchers. The performance materials segment provides specialty chemicals and materials for applications with stringent requirements. The company provides biopharmaceutical and pharmaceutical production, pharmaceutical quality assurance, pharmaceutical research, and academic and government research services.

  • CRYOLAB LTD. - CRYOLAB LTD. offers cryogenic laboratory equipment, accessories, and services to IVF facilities in the UK and Ireland. The company has an extensive domestic and international customer base, servicing the public and private sectors in IVF provision. It is the leading provider of cryogenic equipment to the healthcare industry for fertility, biological research, tissue banking, blood banking, and cell banking. In addition, the company serves a variety of laboratory users who require cryogenic storage.

  • EUROPEAN SPERM BANK - European Sperm Bank (ESB) is a cryobank and a privatelyowned organization in Denmark. It stores and provides a wide range of donated sperm. It provides genetic matching with potential donors to improve the chances of pregnancy as approved by the medical director of the organization. Since its establishment, the company has provided sperms for the birth of more than 30,000 children. It follows guidelines laid down by the EU and WHO. It provides services in more than 90 countries globally.

  • BLOOM IVF CENTER - Bloom IVF Center is a privately held firm with nine state-of-the-art fertility clinics in India. It offers infertility treatments with innovative and advanced reproductive technologies. It offers a wide range of technical and clinical services for couples suffering from infertility and delivers industry-standard ART services, along with the embryology laboratory. To date, the company has offered treatments to more than 20,000 couples from the U.S., India, Canada, the UK, Africa, Europe, Singapore, the UAE, Nepal, and Bangladesh. The average success rate for IVF treatment at the center is over 75%.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Assisted Reproductive Technology Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Assisted Reproductive Technology Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation



This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon